Manon Boisclair

CEO & Founder, InnovID B2; MS, MBA, ICD.D

Role: Associate

Sites: CDL-Montreal, CDL-Oxford, CDL-Rockies, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin

Streams: Advanced Therapies, Artificial Intelligence, Cancer, Health & Wellness, Prime

Manon Boisclair is an entrepreneur and the founder of InnovID B2, a boutique consultancy firm providing tailored consultancy services to C-Suite executives from high growth potential life science companies. Manon has 25 years of international executive management roles with NASDAQ-listed BioPharma companies (Merck, Novartis, Celgene and Intercept) in the US, Canada and Europe. She has extensive global operations, go-to-market, medical/marketing strategy having launched several oncology blockbusters as well as early pipeline compounds across therapeutic areas. Involved in private equity, Manon is an active investor with Anges Quebec as well as a limited partner with Accelia Capital. She has a solid track record in business development, governance, and early stage fundraising (pre-seed to Series B). Manon sits on boards of several privately owned companies- Gray Oncology, MedHelper, Nurse Simple, Ovensa as well as on the board of the Canadian Cancer Society. Active in the startup ecosystem, Manon is a advisor to several MedTech entrepreneurs affiliated with Centech and CTS. Manon has a master in nursing from University of Montreal and an executive MBA from McGill/HEC Montreal. She is a certified corporate board director from the Harvard Business School and the Institute of Corporate Directors.